ACCP is pleased to announce the publication of the second edition of Pharmacogenomics: Applications to Patient Care. The nine-member Pharmacogenomics Editorial Board has recruited experts from many different practice areas, disciplines, and research environments to guide the integration of pharmacogenomics into daily clinical practice.

Pharmacogenomics, the field of study addressing how individual genetic variation affects a patient’s response to drugs, will change how disease is defined, diagnosed, and treated. The application of pharmacogenomic principles is altering how health care providers select and monitor drug therapy. By eliminating the trial-and-error approach to drug selection, pharmacogenomics can promote increased efficacy and decreased toxicity.

Pharmacogenomics offers the opportunity for clinicians to dramatically improve the health outcomes of a large number of patients receiving drug therapy. However, this opportunity is tempered by the challenge of learning the seemingly limitless amount of genetic information assembled during the past decades, together with rapidly emerging new knowledge.

ACCP has developed this textbook to assist clinicians in meeting this challenge. The enhanced second edition, written by experts in the field, combines the basics of pharmacogenomics with disease-specific applications to give clinical pharmacists and other health professionals a solid foundation for understanding the basic science of pharmacogenomics and the skills for integrating pharmacogenomics into daily clinical practice.

Now available in the ACCP online bookstore, Pharmacogenomics: Applications to Patient Care, second edition, is an invaluable publication for students, trainees, and practitioners.

The members of the Pharmacogenomics Editorial Board are Howard L. McLeod, Pharm.D., FCCP (chair); C. Lindsay DeVane, Pharm.D., FCCP, BCPP; Susanne B. Haga, Ph.D.; Julie A. Johnson, Pharm.D., FCCP, BCPS; Daren L. Knoell, Pharm.D., FCCP; Jill M. Kolesar, Pharm.D., FCCP, BCPS; Joseph D. McInerney, M.A., M.S.; P. David Rogers, Pharm.D., Ph.D., FCCP; and Joseph R. Walker, Pharm.D.